Peptide Registry

Vials

Capsules

Liquids

a capsule bottle of TB-500 (Tβ4) 500mcg

TB-500 (Capsules)

$83.00

  • Contents: TB-500 (Thymosin Beta-4 fragment; Ac-LKKTETQ)
  • Format: Encapsulated solid
  • Appearance: White to off-white solid
  • Purity: >99%
Quantity Discount Price
1 - 3 - $83.00
4 - 7 10% $74.70
8 + 18% $68.06
SKU: N/A Category: Brand:

Description

TB-500 (Ac-LKKTETQ) is the actin-sequestering heptapeptide fragment of Thymosin Beta-4, operating through G-actin binding to enable rapid actin polymerization at cell migration leading edges, support endothelial tubulogenesis, and modulate cytoskeletal dynamics in tissue repair models. Capsule format is designed for oral administration research protocols. Oral bioavailability data for TB-500 capsules is limited compared to parenteral routes. Researchers should design appropriate controls when studying this compound through oral versus parenteral delivery in the same experimental system.

Storage and Handling

Store in a cool, dry place away from heat, moisture, and direct light. Keep the container of TB-500 capsules tightly sealed when not in use.

Compliance Notice

TB-500 capsules are for laboratory research use only. They are not for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. FDA has not evaluated this product. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.

Frequently Asked Questions

What should researchers consider when using TB-500 in capsule format?

Published TB-500 research has predominantly used parenteral administration. Oral peptide bioavailability depends on gastric stability and intestinal transport that have not been extensively characterized for this compound. Researchers using capsule format should not assume equivalent bioavailability to parenteral routes without supporting pharmacokinetic data in their specific experimental system.

How does capsule format differ from the vial for TB-500 research?

The vial format is reconstituted for parenteral administration. The capsule format is designed for oral delivery research. The two formats address different experimental conditions and should be selected based on the administration route the research protocol requires.

Related products